Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives.

Diagnostics (Basel) · 2020 · PMC7151145 · PMID 32156035

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

[ 35 ] also reported a positive trend in the response rate of patients with clear-cell OC treated with pembrolizumab.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.